Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4001
World Acceptance Corp
WRLD
$838M
| $116K | ﹤0.01% |
1,760
+463
| +36% | +$36.6K |
|
4002
Bassett Furniture
BSET
$164M
| $116K | ﹤0.01% |
6,665
+6,554
| +5,905% | +$116K |
|
4003
TETRA Technologies
TTI
$1.14B
| $116K | ﹤0.01% |
33,424
+26,026
| +352% | +$101K |
|
4004
Seer Inc
SEER
$122M
| $116K | ﹤0.01% |
19,934
+17,647
| +772% | +$119K |
|
4005
Nomad Foods
NOMD
$1.66B
| $115K | ﹤0.01% |
6,685
-52,144
| -89% | -$826K |
|
4006
CALL
Williams-Sonoma
WSM
$26.9B
| $115K | ﹤0.01% |
+2,000
| New | +$120K |
|
4007
FS KKR Capital
FSK
$2.96B
| $115K | ﹤0.01% |
6,560
-5,741
| -47% | -$107K |
|
4008
ClearPoint Neuro
CLPT
$448M
| $115K | ﹤0.01% |
13,529
+12,781
| +1,709% | +$121K |
|
4009
Stratasys
SSYS
$679M
| $115K | ﹤0.01% |
9,660
-14,101
| -59% | -$188K |
|
|
RJAC
4010
DELISTED
Jackson Acquisition Company
RJAC
| $114K | ﹤0.01% |
11,316
| – | – |
|
4011
Pegasystems
PEGA
$5.02B
| $114K | ﹤0.01% |
6,672
-5,150
| -44% | -$89.1K |
|
4012
Oportun Financial
OPRT
$255M
| $114K | ﹤0.01% |
20,681
+6,376
| +45% | +$33.3K |
|
|
JBIO
4013
Jade Biosciences
JBIO
$1.2B
| $113K | ﹤0.01% |
111
+100
| +909% | +$72.6K |
|
4014
Greif Class B
GEF.B
$4.11B
| $113K | ﹤0.01% |
1,448
+1,157
| +398% | +$84.4K |
|
|
WFH
4015
DELISTED
Direxion Work From Home ETF
WFH
| $113K | ﹤0.01% |
2,800
| – | – |
|
4016
LifeVantage
LFVN
$81.1M
| $113K | ﹤0.01% |
30,358
| – | – |
|
4017
Viemed Healthcare
VMD
$447M
| $113K | ﹤0.01% |
14,901
+13,117
| +735% | +$88.8K |
|
4018
Novartis
NVS
$297B
| $112K | ﹤0.01% |
1,239
-39,091
| -97% | -$3.29M |
|
4019
Mistras Group
MG
$484M
| $112K | ﹤0.01% |
22,736
| – | – |
|
|
ASLN
4020
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $112K | ﹤0.01% |
7,782
-4,000
| -34% | -$77.2K |
|
|
PETQ
4021
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $111K | ﹤0.01% |
12,093
+10,670
| +750% | +$99.6K |
|
4022
KraneShares Global Carbon Strategy ETF
KRBN
$140M
| $111K | ﹤0.01% |
3,053
| – | – |
|
|
REVG
4023
DELISTED
REV Group
REVG
| $111K | ﹤0.01% |
8,817
+7,386
| +516% | +$97.3K |
|
4024
CALL
Newell Brands
NWL
$2.38B
| $111K | ﹤0.01% |
+8,500
| New | +$116K |
|
4025
West Bancorporation
WTBA
$478M
| $111K | ﹤0.01% |
4,351
+2,866
| +193% | +$65.9K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.